Introdução: O Patient Health Questionnaire-9 (PHQ-9) é uma ferramenta breve de triagem e diagnóstico para depressão. Tem sido usado em pesquisa e na prática clínica primária e em outros contextos clínicos e não clínicos. O PHQ-9 não teve sua validade examinada em contextos psiquiátricos e psicológicos no Irã. Métodos: Um estudo transversal foi conduzido para investigar a validação da versão persa do PHQ-9. Uma amostra de conveniência de 130 pacientes psiquiátricos ambulatoriais iranianos foi selecionada em clínicas psiquiátricas e psicológicas. Os pacientes completaram o PHQ-9, Patient Health Questionnaire-15 (PHQ-15), the World Health Organization-five Well-Being Index (WHO-5) e a forma abreviada do Beck Depression Inventory-13 (BDI-13). Os dados foram analisados por estatística descritiva, α de Cronbach, coeficiente de correlação de Pearson, análise de componentes principais e análise fatorial exploratória e confirmatória. Resultados: O escore médio do PHQ-9 foi 12,83 (desvio padrão=6,25), indicando depressão moderadamente severa na amostra. O α de Cronbach para PHQ-9 foi 0,88, e a confiabilidade teste-reteste de uma semana 0,79. O PHQ-9 apresentou correlação de 0,64 com PHQ-15, -0,35 com WHO-5 e 0,70 com BDI-13, indicando boa validade do construto e dos critérios relacionados. Os resultados da análise fatorial dos itens do PHQ-9 identificaram, e a análise fatorial confirmatória confirmou, um único fator, chamado depressão geral. Conclusões: O PHQ-9 parece ter uma estrutura unidimensional, validade e confiabilidade adequadas, e pode ser útil em contextos epidemiológicos e de pesquisa. Com base na literatura prévia e neste estudo, o PHQ-9 pode ter aplicabilidade em outros contextos na população estudada, mas isso precisa ser confirmado. Descritores: Depressão, validade, confiabilidade, estrutura fatorial, Patient Health Questionnaire-9, pacientes psiquiátricos ambulatoriais, Irã.
Introduction
Depression is an important public health problem and the most common mental disorder in primary care.
It is estimated that depression will be the second biggest cause of disability worldwide by 2020. 1 The symptoms of depression are specific (depressed mood, loss of interest in activities, impaired concentration, feelings of worthlessness or guilt, and suicidal ideation), and may include general symptoms of distress found not only in depression, but also in other psychiatric and medical syndromes (somatic symptoms, abdominal pain, back pain, change in weight or appetite, constipation, fatigue, headache, insomnia or hypersomnia, joint pain, neck pain, and weakness). 2 Depression is correlated with several chronic and other illnesses, and also with factors that increase the risk for those illnesses. Some risk factors for depression include younger age, female sex, single/divorced/widowed status, low income, job loss, chronic medical illness, chronic minor daily stress, chronic pain syndrome, family history of depression, low self-esteem, low social support, prior depression, and traumatic brain injury.
2,3
The economic burden of depression includes workplace costs, direct costs and suicide-related costs.
Studies have reported a prevalence of mood disorders of 9.3%, and of major depression disorder (MDD) of 8.2% 4 ; depression has been shown to be associated with suicide thoughts and attempted suicide in Iranian samples. 5, 6 Many tools have been developed for depression screening, e.g. the Beck Depression Inventory (BDI),
Center for Epidemiological Studies -Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital
Anxiety and Depression Scale (HADS), and Primary
Care Evaluation of Mental Disorders -Mood Module (PRIME-MD).
1,7
The PRIME-MD is a rapid procedure and diagnostic instrument designed to identify individuals with mental disorders in primary care. The two components of the original PRIME-MD were combined into a three-and four-page, self-administered version called PRIME-MD Patient Health Questionnaire (PHQ). The PHQ has modules for five common types of mental disorders: depressive, anxiety, somatoform, alcohol, and eating disorders. A two-page version, the Brief PHQ, has also been developed. The Patient Health Questionnaire-9 (PHQ-9) is the depression module of the PHQ.
9-11
The PHQ-9 is a self-report screening tool to aid in diagnosing and measuring the severity of depression and dysthymic disorder. 8, [10] [11] [12] [13] [14] [15] [16] [17] The PHQ-9 has been utilized in research, clinical practice, and epidemiological surveys of mental health. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] It can be administered in person or over the telephone.
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The PHQ-9 is free to users and is available in English There are compelling reasons for using the PHQ-9 as a measure for depression, since cultural, religious, and ethnic factors can influence the severity of depression.
Despite the good characteristics of the PHQ-9 and its applicability in English-speaking persons and several other different languages, there are no published studies on the validation of the PHQ-9 for Iranian psychiatric outpatients. The PHQ-9 would be useful in personality research and in clinical practice, but there is a need to estimate the psychometric properties of the instrument. Thus, the aim of the present study was to examine and explore the validity, reliability and factorial structure (exploratory and confirmatory factor analysis to test for previous factor structures) of the PHQ-9 to assess construct validity in a clinical sample of Iranian psychiatric outpatients. 
Methods

Measures
The Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a self-administered scale used for screening, assessing, and monitoring depression severity. 50 The PHQ-9 has nine items and the answers refer to the past two weeks. Nine items assess symptoms, and one of them assesses functional impairment. Each item is scored using a 4-point Likert scale ranging from 0 to 3: not at all (0), several days (1), more than half the days (2), and nearly every day (3). The PHQ-9 total score for the nine items may range from 0 to 27. A score ≥15 is classified as major depression‚ and ≥20 as severe major depression. The diagnostic validity of the PHQ-9 for MDD has been confirmed in eight primary care
and seven obstetric clinics studies. 10 52 reported good psychometric properties of the PHQ-9 for major depression in Chinese outpatients with multiple somatic symptoms. Solem et al. 53 found a Cronbach's α of 0.88 for the PHQ-9 in a
Norwegian-speaking community sample.
The Patient Health Questionnaire-15 (PHQ-15)
The PHQ-15 is a self-administered scale used to screen for somatoform disorders. The test-retest reliability of the WHO-5 was 0.90. 
Results
PHQ-9 reliability
Cronbach's α coefficient for the PHQ-9 was 0.88, indicating high internal consistency (Table 1) . Oneweek test-retest reliability was 0.79.
PHQ-9 inter-item and item-total score correlations
Correlations between individual items and the total score ranged from 0.67 for item 3 to 0.81 for item 7
(all significant at 0.01), indicating moderate to high associations between each item and the scale total score.
Correlations between items ranged from 0.32 for items 1 and 8, to 0.62 for items 6 and 7 (significant at 0.01), indicating moderate association between the items of the scale (Table 2) .
PHQ-9 correlations with other questionnaires
The PHQ-9 score correlated at 0.64 with the PHQ-15, at -0.36 with the WHO-5, and at 0.70 with the BDI-13, indicating moderate to high concurrent validity (Table 2) .
PHQ-9 factor analysis
The criteria used for factor analysis were evaluated using the Kaiser-Meyer- Factor 1 (all 9 items) explained 53.26% of the observed variance and was labeled general depression ( Table 3 ). The confirmatory factor analysis confirmed this component.
Discussion
The aim of this study was to examine the psychometric and screening properties for depression of the PHQ-9 in a sample of Iranian psychiatric outpatients. The mean score of the PHQ-9 indicated moderate depression severity in the sample. The lowest mean score was obtained for item 9 ("Thoughts that 48 showed that overall scores and severity levels were strongly associated with functional and symptom subscales, denoting good construct validity for the PHQ-9. Cronbach's α for the PHQ-9 was 0.88, and one-week test-retest reliability was 0.79, indicating good reliability, consistent with research in other countries. 46, 48, 67, [70] [71] [72] [73] [74] [75] [76] [77] [78] In the present sample, the PHQ-9 had moderate to strong positive associations with measures of mental health (PHQ-15 and BDI-13), expect for the negative association with WHO-5, indicating good construct validity. Findings of Dum et al. 75 showed that the PHQ-9 correlated with BDI-II and with severity levels of alcohol and drug use among substance abuser outpatients.
The convergent validity of the PHQ-9 has been reported to range from 0.56 35 to 0.74. 36 According to Zuithoff et al., 76 the PHQ-9 correlated with functional status measurements, sick days, and number of consultations in the Netherlands primary care. Hyphantis et al. 73 found that the PHQ- Table 2 -Pearson correlation coefficients (r) between PHQ-9 items and with other questionnaires The present study has some limitations that should be taken into consideration. The study investigated the PHQ-9 in a sample of non-hospitalized psychiatric patients, not in the community. Moreover, sample recruitment was not random, but rather by convenience, meaning that these findings cannot be generalized to other samples. Also, we did not follow the patients in order to evaluate therapy responses and feedbacks, so the clinical importance of the PHQ-9 was not investigated.
Despite these limitations, the present findings suggest that the PHQ-9 has a unidimensional structure, good validity and reliability, and is useful and effective in epidemiological and research settings. Based on previous literature and on the current data, we conclude that the PHQ-9 may have applicability in other contexts in the studied population, even though this still needs to be confirmed. The use of confirmatory factor analysis allowed the study to offer further explanation of the rationale for latent structures and the statistical methods used to investigate it. The PHQ-9 may provide an opportunity for researches to conduct cross-cultural comparisons, and future studies should be conducted with diverse populations and different sociodemographic backgrounds.
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